Legato Capital Management LLC bought a new stake in  Electromed, Inc. (NYSEAMERICAN:ELMD – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor  bought 14,226 shares of the medical equipment provider’s stock, valued at approximately $149,000.

A number of other large investors also recently bought and sold shares of ELMD. CWM LLC purchased a new stake in shares of  Electromed during the third quarter worth approximately $26,000.  Standard Family Office LLC acquired a new position in  Electromed in the third quarter valued at approximately $27,000.  Affiance Financial LLC acquired a new position in  Electromed in the fourth quarter valued at approximately $29,000.  Cetera Advisor Networks LLC acquired a new stake in shares of  Electromed in the second quarter valued at approximately $129,000.  Finally, State Street Corp boosted its holdings in shares of  Electromed by 8.3% in the second quarter. State Street Corp now owns 15,736 shares of the medical equipment provider’s stock valued at $152,000 after acquiring an additional 1,207 shares during the period. Institutional investors and hedge funds own  31.95% of the company’s stock.

Several research firms have recently weighed in on ELMD. Lake Street Capital increased their price objective on Electromed from $20.00 to $26.00 and gave the company a “buy” rating in a report on Wednesday, February 15th. TheStreet raised Electromed from a “c” rating to a “b-” rating in a report on Wednesday, February 15th. StockNews.com started coverage on Electromed in a report on Tuesday, April 4th. They set a “strong-buy” rating for the company. Finally, EF Hutton Acquisition Co. I increased their price target on Electromed from $13.50 to $15.00 and gave the stock a “buy” rating in a report on Thursday, February 16th. Three equities research analysts have rated the stock with a buy rating and one  has issued  a strong buy rating to the stock. According to MarketBeat, Electromed presently has an average rating of “Buy” and a consensus price target of $20.50.

Shares of NYSEAMERICAN ELMD opened at $10.15 on Wednesday. The stock has a fifty day moving average price of $11.58 and a 200 day moving average price of $10.82. Electromed, Inc. has a 1-year low of $8.75 and a 1-year high of $13.84. The company has a market cap of $86.38 million, a PE ratio of 44.13 and a beta of 0.41.

Electromed (NYSEAMERICAN:ELMD – Get Rating) last released its quarterly earnings data on Tuesday, February 14th. The medical equipment provider reported $0.11 earnings per share (EPS) for the quarter. The firm had revenue of $11.73 million during the quarter. Electromed had a return on equity of 6.05% and a net margin of 4.76%.

Electromed, Inc engages in the development, manufacture, marketing, and sale of medical equipment. The firm’s products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers.

Want to see what other hedge funds are holding ELMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Electromed, Inc. (NYSEAMERICAN:ELMD – Get Rating).

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.